Gabaergic Function
Gabaergic Function - Related Videos
01:18
Antiepileptic Drugs: GABAergic Pathway Potentiators
0 Views •
2024
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures. The key GABA pathway potentiators used in epilepsy management are as follows. Benzodiazepines are a well-known class of drugs used for their...
10:57
Primary Cell Culture of Purified GABAergic or Glutamatergic Neurons Established through Fluorescence-activated Cell Sorting
0 Views •
Cited by 9 •
2019
This protocol describes a cell sorting based method for the purification and culture of fluorescent GABAergic or glutamatergic neurons from the neocortex and hippocampus of postnatal mice or rats.
02:45
Functional Groups
0 Views •
2020
Functional groups are a group of atoms with characteristic properties, which when linked to the carbon skeleton of a molecule, alter the properties of that molecule. For example, the presence of certain functional groups on a molecule will make them hydrophilic, whereas others will make them hydrophobic. These functional groups are an indispensable part of organic chemistry and important components of biological molecules, such as carbohydrates, proteins, lipids, and nucleic acids. Each...
10:09
Migration, Chemo-Attraction, and Co-Culture Assays for Human Stem Cell-Derived Endothelial Cells and GABAergic Neurons
0 Views •
Cited by 2 •
2020
We present three simple in vitro assays-the long-distance migration assay, the co-culture migration assay, and chemo-attraction assay-that collectively evaluate the functions of human stem cell derived periventricular endothelial cells and their interaction with GABAergic interneurons.
05:00
Transplantation of Human Stem Cell-Derived GABAergic Neurons into the Early Postnatal Mouse Hippocampus to Mitigate Neurodevelopmental Disorders
0 Views •
Cited by 2 •
2022
Transplantation of human pluripotent stem cell-derived GABAergic neurons generated by neuronal programming could be a potential treatment approach for neurodevelopmental disorders. This protocol describes the generation and transplantation of human stem cell-derived GABAergic neuronal precursors into the brains of neonatal mice, allowing long-term investigation of grafted neurons and evaluation of their therapeutic potential.
FAQs
The key distinction is the signaling route. GABA-A receptors directly open ligand-gated chloride channels, whereas GABA-B receptors act through G protein-coupled pathways. Those pathways increase potassium conductance and reduce calcium entry. Comparing these receptor classes helps explain how GABA regulates neuronal excitability through different cellular mechanisms within the central nervous system.
Opening GABA-A chloride channels and increasing potassium conductance through GABA-B pathways restrain neuronal excitability by altering ion movement across neuronal membranes. GABA-B signaling also reduces calcium entry, adding another inhibitory effect. Together, these actions limit excessive neural firing and help maintain coordinated activity in the central nervous system.
By limiting excessive neural firing, GABAergic regulation contributes to susceptibility to seizures and also influences anxiety, sleep, and movement. This broad physiological reach makes the system clinically important across several neurological and related conditions. Its effects connect cellular inhibitory signaling with changes in brain activity that can become medically significant.
Medicines can support treatment by enhancing or mimicking GABAergic signaling. Benzodiazepines, baclofen, and some antiseizure agents are examples identified in this therapeutic context. Their clinical relevance follows from the inhibitory role of GABA, allowing pharmacologic approaches to address anxiety, muscle spasticity, epilepsy, and related neurological disorders.
The supplied medical context links therapeutic manipulation of this system with anxiety, muscle spasticity, epilepsy, and related neurological disorders. These applications reflect different consequences of abnormal or excessive neural activity. GABAergic medicines are therefore relevant to both disorders characterized by seizure susceptibility and conditions involving broader changes in nervous-system function.
Its importance extends across several outcomes because inhibitory signaling helps coordinate overall brain activity rather than controlling only one pathway. The same receptor mechanisms are therefore relevant when considering anxiety, sleep, movement, seizure susceptibility, spasticity, and epilepsy. This connection gives GABAergic function a broad role in interpreting neurological symptoms and treatment strategies.